Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 17, 2021 01:47PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
ryau - Probably the biggest reason is that they can't get the number of shares they want OTC. Also, the OTC is a mostly unregulated wild west show that many of those type of investors aren't interested in. Also there might be warrants attached to a PP that improves the price some. Maybe other reasons I haven't thought of also.